Pertussis vaccines, epidemiology and evolution

M Domenech de Cellès, P Rohani - Nature Reviews Microbiology, 2024 - nature.com
Pertussis, which is caused by Bordetella pertussis, has plagued humans for at least 800
years, is highly infectious and can be fatal in the unvaccinated, especially very young …

Pertussis resurgence: waning immunity and pathogen adaptation–two sides of the same coin

FR Mooi, NAT Van Der Maas… - Epidemiology & Infection, 2014 - cambridge.org
Pertussis or whoo** cough has persisted and resurged in the face of vaccination and has
become one of the most prevalent vaccine-preventable diseases in Western countries. The …

Duration of pertussis immunity after DTaP immunization: a meta-analysis

A McGirr, DN Fisman - Pediatrics, 2015 - publications.aap.org
BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …

Waning Tdap effectiveness in adolescents

NP Klein, J Bartlett, B Fireman, R Baxter - Pediatrics, 2016 - publications.aap.org
METHODS: We modeled pertussis risk in relation to Tdap vaccination status among
adolescents beginning on their 10th birthday. We estimated the hazard ratio (HR) for each …

Seroprevalence studies of pertussis: what have we learned from different immunized populations

AM Barkoff, K Gröndahl-Yli-Hannuksela… - Pathogens and …, 2015 - academic.oup.com
Bordetella pertussis is a pathogen-causing whoo** cough (pertussis) in humans.
Although vaccination against the disease is effective, the bacterium is still circulating among …

Immune senescence and vaccines to prevent herpes zoster in older persons

MJ Levin - Current opinion in immunology, 2012 - Elsevier
Varicella-zoster virus (VZV) T-cell-mediated immunity (VZV-CMI) in older persons prevents
latent VZV in sensory neurons from reactivating to cause herpes zoster. VZV-CMI declines …

[PDF][PDF] Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012

A Zeddeman, M Gent, C Heuvelman, H Heide, M Bart… - 2014 - repository.ubn.ru.nl
Pathogen adaptation has been proposed to contribute to the resurgence of pertussis. A
striking recent example is the emergence of isolates deficient in the vaccine component …

Strategies to control pertussis in infants

G Amirthalingam - Archives of disease in childhood, 2013 - adc.bmj.com
The UK is currently in the midst of a large outbreak of pertussis, with the highest morbidity
and mortality occurring in young unimmunised infants. This review considers the potential …

Licensed pertussis vaccines in the United States: history and current state

NP Klein - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
The United States switched from whole cell to acellular pertussis vaccines in the 1990s
following global concerns with the safety of the whole cell vaccines. Despite high levels of …

[HTML][HTML] Pertussis immunisation strategies to optimise infant pertussis control: A narrative systematic review

E Tessier, D Newport, A Tran, SG Nash, AA Mensah… - Vaccine, 2023 - Elsevier
Objective Countries routinely offering acellular pertussis vaccine, where long-term protection
is not sustained, have the challenge of selecting an optimal schedule to minimise disease …